John R Doubman
CIK 1755311 · View on SEC EDGAR ↗
First SEC filing: Oct. 10, 2018 · Latest: June 26, 2025
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 25, 2025 | BOOM | A | 14,459 | — | — | 14,459 Direct | — | Acquired | (price as of 2026-08-20) |
| Sept. 30, 2019 | CBT | A | 53 | $45.32 | $2,402 | 4,026 Direct | +1.33% | Acquired | 86.8% (price as of 2026-08-20) |
| Sept. 13, 2019 | CBT | A | 29 | $47.23 | $1,370 | 3,973 Direct | +0.74% | Acquired | 79.2% (price as of 2026-08-20) |
| June 14, 2019 | CBT | A | 30 | $45.47 | $1,364 | 3,944 Direct | +0.77% | Acquired | 86.2% (price as of 2026-08-20) |
| March 14, 2019 | CBT | I | 294 | $12.30 | $3,616 | 7,780 Indirect | +3.93% | Acquired | 588.3% (price as of 2026-08-20) |
| March 13, 2019 | CBT | I | 6,248 | — | — | 7,487 Indirect | +504.28% | Acquired | (price as of 2026-08-20) |
| March 8, 2019 | CBT | A | 29 | $43.72 | $1,268 | 3,914 Direct | +0.75% | Acquired | 93.6% (price as of 2026-08-20) |
| Dec. 31, 2018 | CBT | A | 848 | $42.94 | $36,413 | 3,884 Direct | +27.93% | Acquired | 97.1% (price as of 2026-08-20) |
| Dec. 14, 2018 | CBT | A | 23 | $43.77 | $1,007 | 3,036 Direct | +0.76% | Acquired | 93.4% (price as of 2026-08-20) |
| Nov. 20, 2018 | CBT | F | 1,401 | $48.00 | $67,248 | 20,427 Direct | -6.42% | Disposed | 76.4% (price as of 2026-08-20) |
| Nov. 19, 2018 | CBT | A | 5,599 | — | — | 21,828 Direct | +34.50% | Acquired | (price as of 2026-08-20) |
| Nov. 12, 2018 | CBT | F | 970 | $48.45 | $46,996 | 16,229 Direct | -5.64% | Disposed | 74.7% (price as of 2026-08-20) |
| Nov. 9, 2018 | CBT | A | 18,356 | — | — | 18,356 Direct | — | Acquired | (price as of 2026-08-20) |
| Nov. 9, 2018 | CBT | A | 3,600 | — | — | 17,199 Direct | +26.47% | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 30, 2019 | CBT | Phantom Stock Units | Common Stock (53) | — | — | 53 | Acquired |
| Sept. 13, 2019 | CBT | Phantom Stock | Common Stock (29) | — | — | 29 | Acquired |
| June 14, 2019 | CBT | Phantom Stock | Common Stock (30) | — | — | 30 | Acquired |
| March 8, 2019 | CBT | Phantom Stock | Common Stock (29) | — | — | 29 | Acquired |
| Dec. 31, 2018 | CBT | Phantom Stock Units | Common Stock (848) | — | — | 848 | Acquired |
| Dec. 14, 2018 | CBT | Phantom Stock | Common Stock (23) | — | — | 23 | Acquired |
| Nov. 9, 2018 | CBT | Employee Stock Option (Right to Buy) | Common Stock (18,356) | $50.00 | Nov. 8, 2028 | 18,356 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 8 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Oct. 10, 2018 | CBT | Common Stock | — | Direct |
| Oct. 10, 2018 | CBT | Common Stock | 825 | Indirect |
| Oct. 10, 2018 | CBT | Employee Stock Option (Right to Buy)→ Common Stock (4,017) | 4,017 | Direct |
| Oct. 10, 2018 | CBT | Employee Stock Option (Right to Buy)→ Common Stock (2,306) | 2,306 | Direct |
| Oct. 10, 2018 | CBT | Employee Stock Option (Right to Buy)→ Common Stock (2,834) | 2,834 | Direct |
| Oct. 10, 2018 | CBT | Employee Stock Option (Right to Buy)→ Common Stock (13,747) | 13,747 | Direct |
| Oct. 10, 2018 | CBT | Employee Stock Option (Right to Buy)→ Common Stock (12,639) | 12,639 | Direct |
| Oct. 10, 2018 | CBT | Phantom Stock→ Common Stock (3,096) | 3,096 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CBT
President and President, Performance Additives| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2019 | $395,000 | — | — | — | $176,224 | $1,102 | $57,429 | $1,342,913 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.